All In Biotech

Free tool

FAERS Monitor: Canasa

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021252 or its brand name (Canasa, Mesalamine). Reports on generic versions are filed under their own applications.

Reports

28,963

Serious

25,161

87% of reports

Hospitalization

9,606

Death reported

1,991

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • off label use6,585
  • colitis ulcerative4,668
  • drug ineffective4,551
  • condition aggravated3,424
  • diarrhoea2,723
  • haematochezia2,523
  • fatigue2,332
  • abdominal pain2,214
  • weight decreased1,988
  • headache1,960
  • nausea1,929
  • pyrexia1,863
  • frequent bowel movements1,840
  • pain1,709
  • intentional product use issue1,681

Reports by year received

View as table
YearReports
2004109
2005154
2006113
2007159
2008580
2009150
2010292
2011725
2012662
2013232
2014294
2015374
2016466
2017483
2018683
2019827
20201,226
20212,470
20224,197
20234,314
20244,054
20254,005
20262,393

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,025,196 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
colitis ulcerativeSignal4,66884.682.2345,883
frequent bowel movementsSignal1,84053.050.687,555
haematocheziaSignal2,52334.733.479,058
intentional product use issueSignal1,68114.213.520,283
condition aggravatedSignal3,4248.38.021,913
abdominal painSignal2,2147.06.711,329
off label useSignal6,5855.55.425,070
weight decreasedSignal1,9885.25.06,784
pyrexiaSignal1,8633.93.84,105
diarrhoeaSignal2,7233.13.03,908
drug ineffectiveSignal4,5512.52.44,406
headacheSignal1,9602.32.21,436
fatigueSignal2,3322.22.11,538
painSignal1,7092.01.9907
nausea1,9291.81.7671

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.